Davita Inc. Schedules 3Rd Quarter 2024 Investor Conference Call


(MENAFN- PR Newswire) DENVER, Oct. 9, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA ), announced
today that it will hold its quarterly conference call to discuss third quarter results on
Tuesday, October 29, 2024, at
5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.

This call is also being webcast and can be accessed at the DaVita IR web page. You can join this call as follows:

Tuesday, October 29, 2024
Starting at 5:00 p.m. EDT
Webcast can be accessed using this LINK
Dial in number: 877-918-6630
International dial in: 517-308-9042

When calling in, please provide the operator the password "Earnings" and provide your name and company affiliation. Investors unable to listen to the conference call will be able to access a replay via our website at davita. There will be no telephone replay.

About DaVita Inc.
DaVita (NYSE: DVA ) is a health care provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, DaVita has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey-from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of June
30, 2024, DaVita served approximately 265,100 patients at 3,124 outpatient dialysis centers, of which 2,672 centers were located in
the
United States and 452 centers were located in 13 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere.
To learn more, visit
DaVita/About .

Contact Information
Investors:
[email protected]

SOURCE DaVita

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN09102024003732001241ID1108762919


PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.